Methods of treating ovarian cancer with hemp extract

A method for treating ovarian cancer comprising:

• a. administering to a patient an amount of a composition comprising a cannabis extract (CE) and a reduced amount of a chemotherapeutic agent as compared to a recommended amount of the chemotherapeutic agent;
• b. wherein the chemotherapeutic agent is selected from the group consisting of:
• paclitaxel, altretamine, capecitabine, cyclosphosphamide, etoposide, gemcitabine, ifosfamide, itinotecan, doxorubicin, melphalan, pemetrexed, topotecan, binorelbine, carboplatin, cisplatin, docetaxel, and combinations thereof;
• and
• c. wherein the composition comprising the cannabis extract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE and has a pH of between 3.5 and 6, said composition further comprising at least one additional cannabinoid present at between 0.1% and 10% by weight of the CE selected from the group consisting of:
• Δ-9-tetrahydrocannabinol (Δ9-THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), Δ-8-tetrahydrocannabinol (48-THC), cannabichromene (CBC), cannabichromene acid (CBCA), cannabigerol (CBG), cannabigerol acid (CBGA), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabinol (CBN), cannabicyclol (CBL), and combinations thereof.